Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Jay_Hagan
|
| gptkbp:focusesOn |
RNA-targeted therapeutics
microRNA therapeutics |
| gptkbp:foundedYear |
2007
|
| gptkbp:founder |
gptkb:Alnylam_Pharmaceuticals
gptkb:Ionis_Pharmaceuticals |
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Regulus Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:RG-012
RGLS4326 |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:researchInterest |
gptkb:Alport_syndrome
genetic diseases chronic kidney disease |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:RGLS
|
| gptkbp:website |
https://www.regulusrx.com/
|
| gptkbp:bfsParent |
gptkb:Stelios_Papadopoulos
|
| gptkbp:bfsLayer |
7
|